BCRX Biocryst Pharmaceuticals Inc

Biocryst Pharmaceuticals Inc is a pharmaceutical company that designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in the infectious and inflammatory diseases. It has its focus on oral treatments for rare diseases.

$12.48  -0.02 (-0.16%)
As of 11/26/2021 13:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/07/2001
Outstanding shares:  178,869,928
Average volume:  3,499,193
Market cap:   $2,235,874,100
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    09058V103
ISIN:        US09058V1035
Sedol:      2100362
Valuation   (See tab for details)
PE ratio:   -9.84
PB ratio:   65.34
PS ratio:   19.61
Return on equity:   154.22%
Net income %:   -198.88%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy